Company profile for Traws Pharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Traws Pharma is advancing as a clinical-stage biopharmaceutical enterprise, specializing in the development of small molecule oral product candidates tailored for respiratory viral diseases and cancer. Within the realm of viral respiratory illnesses, Traws Pharma is actively pursuing the creation of an oral inhibitor targeting SARS-CoV-2 Mpro (3CL protease). Additionally, the company is spearheading the development of a novel ...
Traws Pharma is advancing as a clinical-stage biopharmaceutical enterprise, specializing in the development of small molecule oral product candidates tailored for respiratory viral diseases and cancer. Within the realm of viral respiratory illnesses, Traws Pharma is actively pursuing the creation of an oral inhibitor targeting SARS-CoV-2 Mpro (3CL protease). Additionally, the company is spearheading the development of a novel oral antiviral drug candidate designed for influenza.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
Newtown, PA 18940
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/13/3187155/0/en/Traws-Pharma-Reports-Third-Quarter-2025-Results-and-Business-Highlights.html

GLOBENEWSWIRE
13 Nov 2025

https://www.prnewswire.com/news-releases/chemdiv-extends-cmc-services-collaboration-for-ratutrelvir-a-potential-best-in-class-covid-19-therapeutic-advancing-in-phase-2-clinical-trials-302599828.html

PR NEWSWIRE
30 Oct 2025

https://www.prnewswire.com/news-releases/dover-delaware--expert-systems-inc-a-leading-life-sciences-accelerator-supports-traws-pharma-phase-2-clinical-studies-of-ratutrelvir--a-novel-ritonavir-free-antiviral-for-covid-19-302592063.html

PR NEWSWIRE
22 Oct 2025

https://www.globenewswire.com/news-release/2025/10/14/3166002/0/en/Traws-Pharma-Doses-First-Patient-with-Ratutrelvir-in-Phase-2-COVID-Studies-Expects-Results-by-Year-End-2025.html

GLOBENEWSWIRE
14 Oct 2025

https://www.globenewswire.com/news-release/2025/10/06/3161578/0/en/Traws-Pharma-Adds-John-Leaman-MD-as-Independent-Director-and-Formalizes-Appointments-of-Two-Key-Executives.html

GLOBENEWSWIRE
06 Oct 2025

https://www.globenewswire.com/news-release/2025/08/18/3134901/0/en/Traws-Pharma-Receives-Approval-to-Proceed-with-Phase-2-COVID-Studies-with-Ratutrelvir-Expects-Results-by-Year-End-2025.html

GLOBENEWSWIRE
18 Aug 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty